Covance Names New Periapproval Services Executives

Monday, December 29, 2008 11:15 AM

Global contract research organization (CRO) Covance has added three new senior executive positions to its periapproval services team. The Princeton, N.J.-based company appointed Glynis Neagle, M.D., vice president for medical affairs; Robert Bader, director for product safety services; and Thomas Noto, vice president for regulatory affairs.

Neagle, who previously served as Covance’s senior director for clinical development, will oversee medical affairs, epidemiology and product safety.

Bader, formerly senior director for global pharmacovigilance and epidemiology at Cephalon, will lead phase IIIb and IV pharmacovigilance programs.

Noto, who has held various senior positions at other CROs, will oversee regulatory affairs.

Other personnel news from the clinical trial industry:

Cincinnati-based CRO Medpace named Bernard Ilson, M.D., medical director. An expert in nephrology with over 21 years experience in clinical drug development, Ilson served as chief medical officer of Cardiokine before joining Medpace.

Praxis, a Nashville, Tenn.-based patient recruitment company, appointed Megan Sturm business development manager, overseeing Praxis’ northeast U.S. and southern California territories. Sturm spent 14 years at Pfizer before joining Praxis in 2006.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 29

WCG sees ePharmaSolutions’ clinical trial portal as the next step in the data evolution, company mission

Cutting-edge advertising can ‘break through the clutter’ for successful patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs